Q3 2024 |
6 |
$87.9M |
+$9.21M |
-$6.25M |
+$2.96M |
MGM, OMF, EVLV, ASTS, HOMB
|
13F-HR |
10/9/2024, 02:20 PM |
Q2 2024 |
6 |
$83.1M |
$0 |
-$4.52M |
-$4.52M |
MGM, OMF, EVLV, GNK, HOMB
|
13F-HR |
7/11/2024, 12:03 PM |
Q1 2024 |
8 |
$100M |
+$10.2M |
-$19M |
-$8.77M |
MGM, OMF, EVLV, GNK, HTZWW
|
13F-HR |
4/10/2024, 10:33 AM |
Q4 2023 |
7 |
$108M |
+$9.55M |
-$30.8M |
-$21.2M |
OMF, MGM, EVLV, HTZWW, GNK
|
13F-HR |
1/9/2024, 11:07 AM |
Q3 2023 |
8 |
$113M |
+$3.91M |
-$9.77M |
-$5.86M |
OMF, MGM, HTZWW, EVLV, ET
|
13F-HR |
10/5/2023, 04:13 PM |
Q2 2023 |
8 |
$141M |
+$13.9M |
-$3.05M |
+$10.8M |
OMF, MGM, HTZWW, HTZ, ET
|
13F-HR |
7/13/2023, 05:49 PM |
Q1 2023 |
8 |
$119M |
+$39.3M |
-$26.5M |
+$12.9M |
OMF, MGM, HTZWW, HTZ, ET
|
13F-HR |
4/5/2023, 02:36 PM |
Q4 2022 |
10 |
$79.1M |
+$1.79M |
-$15.7M |
-$14M |
OMF, HTZ, BYD, ET, ASO
|
13F-HR |
1/24/2023, 02:49 PM |
Q3 2022 |
13 |
$87.2M |
+$25.1M |
-$23.2M |
+$1.81M |
OMF, HTZ, ET, BYD, MFIN
|
13F-HR |
10/25/2022, 04:28 PM |
Q2 2022 |
9 |
$101M |
+$3.21M |
-$9.09M |
-$5.88M |
OMF, ECPG, HTZ, MFIN, ET
|
13F-HR |
7/12/2022, 04:23 PM |
Q1 2022 |
11 |
$130M |
+$14.4M |
-$16M |
-$1.67M |
OMF, ECPG, HTZ, MFIN, ET
|
13F-HR |
4/18/2022, 02:48 PM |
Q4 2021 |
9 |
$133M |
$0 |
$0 |
|
OMF, ECPG, MFIN, EQT, VST
|
13F-HR |
1/27/2022, 05:49 PM |
Q3 2020 |
4 |
$61.4M |
+$850K |
-$935K |
-$85.7K |
OMF, MFIN, EQT, AM
|
13F-HR |
11/12/2020, 12:04 PM |
Q2 2020 |
3 |
$49.2M |
+$1.06M |
-$1.77M |
-$706K |
OMF, MFIN, EQT
|
13F-HR |
8/4/2020, 05:29 PM |
Q1 2020 |
2 |
$38.6M |
$0 |
-$5.44M |
-$5.44M |
OMF, MFIN
|
13F-HR |
5/8/2020, 09:51 AM |
Q4 2019 |
3 |
$101M |
$0 |
$0 |
|
OMF, MFIN, ET
|
13F-HR |
2/14/2020, 09:05 AM |
Q3 2016 |
9 |
$83.2M |
+$6.93M |
-$14.8M |
-$7.82M |
OMF, HOMB, C, PCRX, DYN
|
13F-HR |
11/14/2016, 02:23 PM |
Q2 2016 |
10 |
$78.5M |
+$17M |
-$5.57M |
+$11.4M |
OMF, HOMB, CPN, PCRX, C
|
13F-HR |
8/12/2016, 06:06 AM |
Q1 2016 |
11 |
$90.6M |
+$787K |
-$6.9M |
-$6.12M |
OMF, HOMB, PCRX, CPN, C
|
13F-HR |
5/16/2016, 11:35 AM |
Q4 2015 |
11 |
$48.9M |
+$11.8M |
-$9.81M |
+$2.01M |
HOMB, CPN, C, UPBD, DYN
|
13F-HR |
2/16/2016, 10:39 AM |
Q3 2015 |
13 |
$75.2M |
+$11M |
-$10.3M |
+$665K |
HOMB, PCRX, C, DRII, TBT
|
13F-HR |
11/16/2015, 07:51 AM |
Q2 2015 |
12 |
$85.7M |
+$5.19M |
-$14.1M |
-$8.92M |
HOMB, PCRX, C, DRII, AMBC
|
13F-HR |
8/12/2015, 03:01 PM |
Q1 2015 |
16 |
$102M |
+$6.62M |
-$17M |
-$10.4M |
HOMB, PCRX, AMBC, DRII, C
|
13F-HR |
5/15/2015, 01:44 PM |
Q4 2014 |
21 |
$110M |
+$28M |
-$41M |
-$13M |
HOMB, PCRX, AMBC, DRII, DYN
|
13F-HR |
2/13/2015, 02:15 PM |
Q3 2014 |
20 |
$115M |
+$17.6M |
-$34.9M |
-$17.2M |
HOMB, AMBC, C, PCRX, DRII
|
13F-HR |
11/14/2014, 03:13 PM |
Q2 2014 |
19 |
$139M |
+$23.1M |
-$17.7M |
+$5.41M |
C, AMBC, HOMB, AAL, DRII
|
13F-HR |
8/14/2014, 11:28 AM |
Q1 2014 |
18 |
$135M |
+$36.3M |
-$26.2M |
+$10.1M |
C, AMBC, HOMB, AAL, DRII
|
13F-HR |
5/15/2014, 02:05 PM |
Q4 2013 |
19 |
$117M |
$0 |
$0 |
|
AMBC, HOMB, AAL, TMV, AGO
|
13F-HR |
2/14/2014, 11:29 AM |